1) Stabin, M. G., Sparks, R. B. and Crowe, E., OLINDA/EXM:the second-generation personal computer software for internal dose assessment in nuclear medicine, J. Nucl. Med., 46, 1023-1027(2005)
2) Ikeda, T., Aoyama, S., Tozuka, Z., Nozawa, K., Hamabe, Y., Matsui, T., Kainuma, M., Hasegawa, S., Maeda, K. and Sugiyama, Y., Microdose pharmacogenetic study of 14C-tolbutamide in healthy subjects with accelerator mass spectrometry to examine the effects of CYP2C9*3 on its pharmacokinetics and metabolism, Eur. J. Pharm. Sci., 49, 642-648(2013)
3) Tozuka, Z., Kusuhara, H., Nozawa, K., Hamabe, Y., Ikushima, I., Ikeda, T. and Sugiyama, Y., Microdose study of 14C-acetaminophen with accelerator mass spectrometry to examine pharmacokinetics of parent drug and metabolites in healthy subjects, Clin. Pharmacol. Ther., 88, 824-830(2010)
4) Yamazaki, H., Kunikane, E., Nishiyama, S., Murayama, N., Shimizu, M., Sugiyama, Y., Chiba, K. and Ikeda, T., Human plasma concentrations of tolbutamide and acetaminophen extrapolated from in vivo animal pharmacokinetics using in vitro human hepatic clearances and simple physiologically based pharmacokinetic modeling for radio-labeled microdose clinical studies, RADIOISOTOPES, 64, 509-519(2015)